H.C. Wainwright Adjusts Price Target on Acurx Pharmaceuticals to $12 From $14, Keeps Buy Rating
MT NewswiresMar 19 21:32
Acurx Pharmaceuticals Analyst Ratings
BenzingaMar 19 18:27
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12
BenzingaMar 19 18:32
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $14 Price Target
BenzingaFeb 29 01:53
Buy Rating for Acurx Pharmaceuticals Amid Promising Phase 2 Results and Positive Regulatory Momentum
TipRanksFeb 28 19:39
Analysts' Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)
TipRanksJan 23 02:21
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH), Lisata Therapeutics (LSTA) and Acurx Pharmaceuticals (ACXP)
TipRanksJan 23 01:31
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $14
BenzingaDec 15, 2023 19:36
Acurx Pharmaceuticals Analyst Ratings
BenzingaDec 15, 2023 19:35
Promising Future for Acurx Pharmaceuticals: A Buy Rating Backed by Strong Financials, Successful Clinical Trials, and Strategic Market Positioning
TipRanksNov 16, 2023 01:15
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $13 Price Target
BenzingaNov 15, 2023 23:24
Acurx Pharmaceuticals Analyst Ratings
BenzingaNov 15, 2023 23:22
Promising Trials and Undervaluation Make Acurx Pharmaceuticals a Buy: An Analysis of ACXP's Potential
TipRanksNov 3, 2023 23:35
Buy Rating on Acurx Pharmaceuticals: Promising Clinical Results and Financial Stability Highlighted by Analyst Ed Arce
TipRanksNov 3, 2023 00:39
Maxim Raises Price Target on Acurx Pharmaceuticals to $10 From $7, Keeps Buy Rating
MT NewswiresOct 12, 2023 00:56
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Acurx Pharmaceuticals (ACXP)
TipRanksOct 2, 2023 23:40
H.C. Wainwright Sticks to Its Buy Rating for Acurx Pharmaceuticals (ACXP)
TipRanksSep 13, 2023 18:25
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $13 Price Target
BenzingaSep 13, 2023 18:24
Acurx Pharmaceuticals Analyst Ratings
BenzingaSep 13, 2023 18:24
Maxim Group Remains a Buy on Acurx Pharmaceuticals (ACXP)
TipRanksAug 16, 2023 02:45
No Data
No Data